Yayın: Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus
| dc.contributor.buuauthor | Ersoy, Alparslan | |
| dc.contributor.buuauthor | Ersoy, Canan | |
| dc.contributor.buuauthor | Tekçe, Hikmet | |
| dc.contributor.buuauthor | Yavaşçaoǧlu, İsmet | |
| dc.contributor.buuauthor | Dilek, Kamil | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Nefroloji Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-0710-0923 | |
| dc.contributor.researcherid | AAH-5054-2021 | |
| dc.contributor.scopusid | 35612977100 | |
| dc.contributor.scopusid | 6701485882 | |
| dc.contributor.scopusid | 16687238400 | |
| dc.contributor.scopusid | 6603612497 | |
| dc.contributor.scopusid | 56005080200 | |
| dc.date.accessioned | 2022-05-05T10:45:46Z | |
| dc.date.available | 2022-05-05T10:45:46Z | |
| dc.date.issued | 2004-06 | |
| dc.description.abstract | Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus. | |
| dc.identifier.citation | Ersoy, A. vd. (2004). “Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus”. Transplantation Proceedings, 36(5), 1407-1410. | |
| dc.identifier.doi | 10.1016/j.transproceed.2004.04.080 | |
| dc.identifier.endpage | 1410 | |
| dc.identifier.issn | 0041-1345 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pubmed | 15251345 | |
| dc.identifier.scopus | 2-s2.0-3142538604 | |
| dc.identifier.startpage | 1407 | |
| dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2004.04.080 | |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0041134504005123 | |
| dc.identifier.uri | http://hdl.handle.net/11452/26288 | |
| dc.identifier.volume | 36 | |
| dc.identifier.wos | 000222713000049 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science | |
| dc.relation.journal | Transplantation Proceedings | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Immunology | |
| dc.subject | Surgery | |
| dc.subject | Transplantation | |
| dc.subject | Kidney-transplantation | |
| dc.subject | Allograft recipients | |
| dc.subject | Patient survival | |
| dc.subject | Randomized-trial | |
| dc.subject | Risk-factors | |
| dc.subject | Mellitus | |
| dc.subject | Immunosuppression | |
| dc.subject | Cyclosporine | |
| dc.subject | Insulin | |
| dc.subject | FK506 | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Clinical feature | |
| dc.subject.emtree | Diabetes mellitus | |
| dc.subject.emtree | Diabetic ketoacidosis | |
| dc.subject.emtree | Disease course | |
| dc.subject.emtree | Drug dose reduction | |
| dc.subject.emtree | Female | |
| dc.subject.emtree | Follow up | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Immunosuppressive treatment | |
| dc.subject.emtree | Kidney graft rejection | |
| dc.subject.emtree | Kidney transplantation | |
| dc.subject.emtree | Laboratory test | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Treatment failure | |
| dc.subject.emtree | Treatment outcome | |
| dc.subject.emtree | Bicarbonate | |
| dc.subject.emtree | Infusion fluid | |
| dc.subject.emtree | Insulin | |
| dc.subject.emtree | Sodium chloride | |
| dc.subject.emtree | Tacrolimus | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Diabetic ketoacidosis | |
| dc.subject.mesh | Drug therapy, combination | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Immunosuppressive agents | |
| dc.subject.mesh | Kidney transplantation | |
| dc.subject.mesh | Peritoneal dialysis, continuous ambulatory | |
| dc.subject.mesh | Postoperative complications | |
| dc.subject.mesh | Tacrolimus | |
| dc.subject.mesh | Treatment outcome | |
| dc.subject.scopus | Kidney Transplantation; Diabetes Mellitus; Transplant Recipients | |
| dc.subject.wos | Immunology | |
| dc.subject.wos | Surgery | |
| dc.subject.wos | Transplantation | |
| dc.title | Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Nefroloji Bilim Dalı | |
| local.indexed.at | PubMed | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
